You just read:

Biohaven's Rimegepant Positive Phase 3 Trial For Acute Treatment Of Migraine Published In The New England Journal of Medicine

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

Jul 10, 2019, 17:00 ET